Nine new
cadinane-type
sesquiterpenoids (1-9) and three new eucalyptane -type
sesquiterpenes (10-12) were isolated from the
ethyl acetate extract of Burdock leaves, which were commonly used for preventing or treating
atherosclerosis in China. Their structures were confirmed by extensive spectroscopic analysis, single-crystal X-ray diffraction analysis and ECD calculations. Compound 1 possessed the rare large conjugated skeleton. All the isolates were evaluated for anti-inflammatory and
cholesterol-lowering activities by the LPS- and
oxidized-low-density-lipoprotein-stimulated RAW 264.7 cells, respectively. As the results, all isolates could decrease the productions of NO, and down-regulate the accumulation of
cholesterol. Among them, 4 showed the most potent
cholesterol-lowering effect. For the high content of 4 in the herb, mechanistic study of 4 was performed and the results showed that 4 markedly reduced the release of pro-inflammatory mediators which was probably associated with inhibition of the PI3K/Akt and 5-LOX signaling pathways. The findings of this study demonstrated the anti-inflammatory/
cholesterol-lowering effects of the new
sesquiterpenes from burdock leaves, which provides chemical basis and scientific evidence for the herb used as anti-
atherosclerosis agents for the further study. The
sesquiterpene lactones of burdock leaves are expected to become new small molecule inhibitors for the treatment of AS.